<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/31-1373.11"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/31-1373.11/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_31_1373_11">
        <akn:num>31-1373.11</akn:num>
        <akn:heading>Derivative transactions.</akn:heading>
<akn:subsection eId="subsec_31-1373_11_a">
      <akn:num>(a)</akn:num>
      <akn:content><akn:p>An insurer may, directly or indirectly through an investment subsidiary, engage in derivative transactions under this section, subject to the requirements of this section.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_31-1373_11_b">
      <akn:num>(b)</akn:num>
      <akn:content><akn:p></akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_31-1373_11_c">
      <akn:num>(c)</akn:num>
      <akn:content><akn:p>An insurer may enter into hedging transactions under this section if, as a result of and after giving effect to the transaction:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_31-1373_11_d">
      <akn:num>(d)</akn:num>
      <akn:content><akn:p>An insurer may enter into the following types of income generation transactions if, as a result of and after giving effect to the transactions, the aggregate statement value of the fixed income assets that are subject to call, the face value of fixed income securities underlying a derivative instrument subject to call, and the amount of the purchase obligations under the puts, do not exceed 10% of its admitted assets:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_31-1373_11_e">
      <akn:num>(e)</akn:num>
      <akn:content><akn:p>An insurer shall include all counterparty exposure amounts in determining compliance with the limitations of ยง 31-1373.03.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_31-1373_11_f">
      <akn:num>(f)</akn:num>
      <akn:content><akn:p>Under regulations promulgated under ยง 31-1375.01, the Commissioner may approve additional transactions involving the use of derivative instruments in excess of the limits of subsection (c) of this section or for other risk management purposes under regulations promulgated by the Commissioner; provided, that replication transactions shall not be permitted for other than risk management purposes.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
